Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results

Nuvalent, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
10/13/2023 8-K Quarterly results
10/06/2023 4 Turner Christopher Durant (Chief Medical Officer) has filed a Form 4 on Nuvalent, Inc.
Txns: Sold 2,665 shares @ $51.32, valued at $136.8k
Sold 2,265 shares @ $53.7, valued at $121.6k
Sold 600 shares @ $54.32, valued at $32.6k
Sold 500 shares @ $55.84, valued at $27.9k
Sold 500 shares @ $57.18, valued at $28.6k
Sold 1,465 shares @ $57.7, valued at $84.5k
Exercised 7,995 options to buy @ $6.89, valued at $55.1k
10/06/2023 4 Noci Darlene (Chief Development Officer) has filed a Form 4 on Nuvalent, Inc.
Txns: Sold 14,600 shares @ $55.41, valued at $809k
Sold 5,400 shares @ $57.54, valued at $310.7k
Exercised 4,587 options to buy @ $1.08, valued at $5k
Exercised 15,413 options to buy @ $6.89, valued at $106.2k
10/04/2023 4 Noci Darlene (Chief Development Officer) has filed a Form 4 on Nuvalent, Inc.
Txns: Sold 745 shares @ $45.35, valued at $33.8k
Sold 2,144 shares @ $46.01, valued at $98.6k
Sold 111 shares @ $47.01, valued at $5.2k
Exercised 3,000 options to buy @ $1.08, valued at $3.2k
10/04/2023 144 Form 144 - Report of proposed sale of securities:
10/04/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Preliminary Phase 1 Dose-Escalation Data from ALKOVE-1 Trial of NVL-655 Demonstrated Activity in Heavily Pre-Treated Patients with ALK-Positive NSCLC and an ALK-Selective, TRK-Sparing Safety Profile"
08/17/2023 4 Miller Deborah Ann (Chief Legal Officer) has filed a Form 4 on Nuvalent, Inc.
Txns: Sold 1,291 shares @ $42.46, valued at $54.8k
Sold 709 shares @ $43.01, valued at $30.5k
Exercised 2,000 options to buy @ $6.89, valued at $13.8k
08/10/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/10/2023 8-K Quarterly results
Docs: "SELECTED STATEMENTS OF OPERATIONS DATA 30, Six Months Ended June 30, 2023 2022 2023 2022 Operating expenses: Research and development $ 25,922 $ 13,558 $ 48,047 $ 26,251 General and administrative 8,140 5,175 16,225 10,170 Total operating expenses 34,062 18,733 64,272 36,421 Loss from operations Other income : Interest income and other income , net 4,972 267 9,990 406 Total other income, net 4,972 267 9,990 406 Net loss $ $ $ $ Net loss per share attributable to common stockholders, basic and diluted $ $ $ $ Weighted average shares of common stock outstanding, basic and diluted 56,866,991 48,319,067 56,785,883 48,302,017 SELECTED BALANCE SHEET DATA June 30, December 31, 2023 2022 Cash, cash equivalents and marketable securities $ 431,239 $ 472,163 Working capital $ 416,197 $ 458,510 To..."
08/01/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/01/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/01/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/31/2023 144 Form 144 - Report of proposed sale of securities:
07/28/2023 144 Form 144 - Report of proposed sale of securities:
07/28/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/28/2023 144 Form 144 - Report of proposed sale of securities:
07/24/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/21/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/19/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/17/2023 144 Form 144 - Report of proposed sale of securities:
07/06/2023 4 Noci Darlene (Chief Development Officer) has filed a Form 4 on Nuvalent, Inc.
Txns: Sold 2,447 shares @ $41.33, valued at $101.1k
Sold 553 shares @ $42.12, valued at $23.3k
Exercised 3,000 options to buy @ $1.08, valued at $3.2k
06/16/2023 4 Flynn James E (10% Owner) has filed a Form 4 on Nuvalent, Inc.
Txns: Granted 15,000 options to buy @ $44.68, valued at $670.2k
06/16/2023 4 Hack Andrew A. F. (Director) has filed a Form 4 on Nuvalent, Inc.
Txns: Granted 15,000 options to buy @ $44.68, valued at $670.2k
06/16/2023 144 Form 144 - Report of proposed sale of securities:
06/16/2023 4 Wheeler Cameron (Director) has filed a Form 4 on Nuvalent, Inc.
Txns: Granted 15,000 options to buy @ $44.68, valued at $670.2k
06/16/2023 4 Pearlberg Joseph (Director) has filed a Form 4 on Nuvalent, Inc.
Txns: Granted 15,000 options to buy @ $44.68, valued at $670.2k
06/16/2023 4 Srivastava Sapna (Director) has filed a Form 4 on Nuvalent, Inc.
Txns: Granted 15,000 options to buy @ $44.68, valued at $670.2k
06/16/2023 4 Shair Matthew (Director) has filed a Form 4 on Nuvalent, Inc.
Txns: Granted 15,000 options to buy @ $44.68, valued at $670.2k
06/16/2023 4 Protopapas Anna (Director) has filed a Form 4 on Nuvalent, Inc.
Txns: Granted 15,000 options to buy @ $44.68, valued at $670.2k
06/16/2023 4 Meyers Michael L. (Director) has filed a Form 4 on Nuvalent, Inc.
Txns: Granted 15,000 options to buy @ $44.68, valued at $670.2k
06/16/2023 4 Gilliland Dwight Gary (Director) has filed a Form 4 on Nuvalent, Inc.
Txns: Granted 15,000 options to buy @ $44.68, valued at $670.2k
06/16/2023 4 Conley Emily (Director) has filed a Form 4 on Nuvalent, Inc.
Txns: Granted 15,000 options to buy @ $44.68, valued at $670.2k
06/16/2023 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders...
Docs: "THIRD AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF NUVALENT, INC. Nuvalent, Inc., a corporation organized and existing under the laws of the State of Delaware , hereby certifies as follows: 1. The name of the Corporation is Nuvalent, Inc. The date of the filing of its original Certificate of Incorporation with the Secretary of State of the State of Delaware was January 25, 2017 . 2. This Third Amended and Restated Certificate of Incorporation amends, restates and integrates the provisions of the Amended and Restated Certificate of Incorporation that was filed with the Secretary of State of the State of Delaware on April 30, 2021 , and was duly adopted in accordance with the provisions of Sections 228, 242 and 245 of the General Corporation Law of the State of Delaware . 3. The text..."
06/07/2023 4 Turner Christopher Durant (Chief Medical Officer) has filed a Form 4 on Nuvalent, Inc.
Txns: Sold 10,235 shares @ $44.86, valued at $459.1k
Exercised 10,235 options to buy @ $6.89, valued at $70.5k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy